Oxidative injury in epilepsy: potential for antioxidant therapy?

References

• Brodie MJ, Dichter MA. Antiepileptic drugs. N. Engl. Med 334, 168–175 (1996).
   PubMed Web of Science ®Google Scholar
• Schwartzkroin PA. Basic mechanisms of epileptogenesis. In: The Treatment of Epilepsy: Principles and Practice. Wyllie E (Ed.). Williams & Wilkins, MD, USA, 106–121 (1997).
   Google Scholar
• Babb TL, Pretorius JK. Pathological substrates of epilepsy. In: The Treatment of Epilepsy: Principles and Practice. Wyllie E (Ed.). Williams & Wilkins, MD, USA, 106–121 (1997).
   Google Scholar
• Johnston MV. Neurotransmitters and Epilepsy. In: The Treatment of Epilepsy: Principles and Practice. Wyllie E (Ed.). Williams & Wilkins, MD, USA, 122–138 (1997).
   Google Scholar
• Meldrum BS. Identification and preclinical testing of novel antiepileptic compounds. Epilepsia 38, S7—S15 (1997).
   Web of Science ®Google Scholar
• Biervert C, Schroeder BC, Kubisch C et al A potassium channel mutation in neonatal human epilepsy. Science 279, 403–406 (1998).
   PubMed Web of Science ®Google Scholar
• Ames BN, Shigenaga MK, Hagen TM. Oxidants, antioxidants and the degenerative diseases of aging. Proc. Natl Acad. Li. USA 90, 7915–7922 (1993).
   Google Scholar
• Marnett LJ, Hurd H, Hollstein MC, Esterbauer DE, Ames BN. Naturally occurring carbonyl compounds are mutagens in Salmonella tester strain TA104. Mutat. Res. 148, 25–34 (1985).
   Google Scholar
• Wei YH, Lee HC. Oxidative stress, mitochondrial DNA mutation and impairment of antioxidant enzymes in aging. Experiment. Biol. Med. 227, 671–682 (2002).
   PubMed Web of Science ®Google Scholar
• •Provides a synopsis of current thinking on the role played by oxidative injury in aging.
   Google Scholar
• Chance B, Sies H, Boveris A. Hydroperoxide metabolism in mammalian organs. Physiol Rev 59, 527–605 (1979).
   Google Scholar
• Ratan RR, Murphy TH, Baraban JM. Oxidative stress induces apoptosis in embryonic cortical neurons. j Neurochem. 62, 376–379 (1994).
   Google Scholar
• Whittemore ER, Loo DT, Cotman CW. Exposure to hydrogen peroxide induces cell death via apoptosis in cultured rat cortical neurons. Neuromport5, 1485–1488 (1994).
   Google Scholar
• Geller HM, Cheng KY, Goldsmith NK et al. Oxidative stress mediates neuronal DNA damage and apoptosis in response to cytosine arabinoside. j Neurochem. 78, 265–275 (2001).
   PubMedGoogle Scholar
• Greenlund LJ, Deckwerth TL, Johnson EM. Superoxide dismutase delays neuronal apoptosis: a role of reactive oxygen species in programmed neuronal death. Neumn 14, 303–315 (1995).
   Google Scholar
• Stoian I, Oros AA, Moldoveanu E. Apoptosis and free radicals. Biochem. Mal Med. 59, 93–97 (1996).
   PubMedGoogle Scholar
• Chan PH, Chu L, Chen SF, Carlson EJ, Epstein CJ. Reduced neurotoxicity in transgenic mice overexpressing human copper—zinc—superoxide dismutase. Stroke 21\(Suppl. 11), 80–82 (1990).
   Google Scholar
• Martin KR Barrett JC. Reactive oxygen species as double-edged swords in cellular processes: low-dose cell signalling versus high-dose toxicity. Hum. ET. Toxicol. 21, 71–75 (2002).
   Google Scholar
• Sen CK, Packer L. Antioxidant and redox regulation of gene transcription. FASEB I 10, 709–720 (1996).
   PubMed Web of Science ®Google Scholar
• Hensley K, Robinson KA, Gabbita SP, Salsman S, Floyd RA. Reactive oxygen species, cell signalling and cell injury. Free Radic. Biol. Med. 28, 1456–1462 (2000).
   Google Scholar
• Crow JP, Ischiropoulos H. Detection and quantification of nitrotyrosine residues in proteins: in vivo marker of peroxynitrite. Method Enzymol 269, 185–194 (1996).
   PubMed Web of Science ®Google Scholar
• Ischiropoulos H, Gow A, Thom SR, Kooy NW Royall JA, Crow JR Detection of reactive nitrogen species using 2,7-dichlorodihydrofluorescein and dihydrorhodamine 123. Methods Etzzymol. 301, 367–373 (1999).
   PubMed Web of Science ®Google Scholar
• Buss H, Chan TP, Sluis KB, Domigan NM, Winterbourn CC. Protein carbonyl measurement by a sensitive ELISA method. Free Radic. Biol. Med. 23, 361–366 (1997).
   PubMed Web of Science ®Google Scholar
• Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ II. A series of prostaglandin F2-like compounds are produced in vivo in humans by a noncyclooxygenase, free radical-catalyzed mechanism. Proc. Natl Acad. Li. USA 87, 9383–9387 (1990).
   Google Scholar
• Delanty N, Reilly M, Pratico D, Fitzgerald DJ, Lawson JA, Fitzgerald GA. 8-Epi PGF2 a: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. BE J. Clin. Pharmacol 42, 15–19 (1996).
   Google Scholar
• Helbock HJ, Beckman KB, Ames BN. 8- Hydroxydeoxyguanosine and 8-hydroxyguanine as biomarkers of oxidative DNA damage. Methods Etzzymol 300, 156–166 (1999).
   Google Scholar
• Halliwell B, Gutteridge J. Free Radicals in Biology and Medicine. Third Edition. Oxford University Press, Oxford, UK.
   Google Scholar
• ••Currendt the best reference text on free radical pathobiology.
   Google Scholar
• Beal MF, Ferrante RJ, Browne SE, Matthews RT, Kowall NW, Brown RII Jr.Increased 3-nitrotyrosine in both sporadic and familial amyotrophic lateral sclerosis. Ann. Neural 42, 644–654 (1997).
   Google Scholar
• Przedborski S, Donaldson DM, Murphy PL etal. Blood superoxide dismutase, catalase and glutathione peroxidase activities in familial and sporadic amyotrophic lateral sclerosis. Neumdegeneration 5, 57–64 (1996).
   Google Scholar
• Przedborski S, Donaldson D, Jakowec M et al. Brain superoxide dismutase, catalase and glutathione peroxidase activities in amyotrophic lateral sclerosis. Ann. Neural. 39, 158–165 (1996).
   PubMed Web of Science ®Google Scholar
• Butterfield DA, Lauderback CM. Lipid peroxidation and protein oxidation in Alzheimer's disease brain: potential causes and consequences involving amyloid - peptide-associated free radical oxidative stress. Free Radic. Biol. Med. 32, 1050–1060 (2002).
   PubMed Web of Science ®Google Scholar
• Markesbery WR, Carney JM. Oxidative alterations in Alzheimer's disease. Brain Athol 9, 133–146 (1999).
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Eng" J. Med. 320, 915–924 (1989).
   Google Scholar
• Salonen JT, Yla-Herttuala S, Yamamoto R et al Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 339, 883–887 (1992).
   PubMed Web of Science ®Google Scholar
• Pulsinelli W Pathophysiology of acute ischaemic stroke. Lancet 339, 533–536 (1992).
   Google Scholar
• Hall ED, McCall JM, Means ED. Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischaemia and subarachnoid hemorrhage Adv. Pharmacol. 28, 221–268 (1994).
   Google Scholar
• Browne SE, Bowling AC, MacGarvey U et al Oxidative damage and metabolic dysfunction in Huntington's disease: selective vulnerability of the basal ganglia. Ann. Neural 41, 646–653 (1997).
   PubMed Web of Science ®Google Scholar
• Sian J, Dexter DT, Lees AJ, Daniel S, Jenner P, Marsden CD. Glutathione-related enzymes in brain in Parkinson's disease. Ann. Neural 36, 356–361 (1994).
   PubMed Web of Science ®Google Scholar
• Jenner P, Dexter DT, Sian J, Schapira AH, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. The Royal
   Google Scholar
• •• Kings and Queens Parkinson's disease Research Group. Ann. Neural. 32, S82—S87 (1992).
   Google Scholar
• Gotoda T, Arita M, Arai H et al Adult- onset spinocerebellar dysfunction caused by a mutation in the gene for the a-tocopherol-transfer protein. N Engl. Med. 16,1313–1318 (1995).
   Google Scholar
• Yokota T, Shiojiri T, Gotoda T et al Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the a-tocopherol transfer protein gene. Ann. Neural. 41,826-832 (1997).
   Google Scholar
• Shohami E, Gati I, Beit-Yannai E, Trembovler V, Kohen R. Closed head injury in the rat induces whole body oxidative stress: overall reducing antioxidant profile. I Neurotrauma 16, 365–376 (1999).
   PubMed Web of Science ®Google Scholar
• Marshall LF, Maas AI, Marshall SB et al A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. Neurosurg. 89,519–525 (1998).
   Web of Science ®Google Scholar
• Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LE Failure of the competitive N-methyl-D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: results of two Phase III clinical trials. The Selfotel Investigators.' Neurosurg. 91,737-743 (1999).
   Google Scholar
• Geromel V, Darin N, Chretien D et al. Coenzyme Q (10) and idebenone in the therapy of respiratory chain diseases: rationale and comparative benefits. Mal Genet. Metab. 77,21-30 (2002).
   Google Scholar
• Wei YH, Lee HC. Mitochondrial DNA mutations and oxidative stress in mitochondrial diseases. Adv. Clin. Chem. 37,83–128 (2003).
   PubMed Web of Science ®Google Scholar
• Delanty N, Dichter MA. Oxidative injury in the nervous system. Acta Neural. Land. 98,145–153 (1998).
   PubMed Web of Science ®Google Scholar
• Jenner P. Oxidative damage in neurodegenerative disease. Lancet 344, 796–798 (1994).
   PubMed Web of Science ®Google Scholar
• Avshalumov MV, Rice ME. NMDA receptor activation mediates hydrogen peroxide-induced pathophysiology in rat hippocampal slices. I Neurophysiol 87, 2896–2903 (2002). Outlines the direct evidence that free radical exposure can directly lead to neuronal hyperexcitability.
   Google Scholar
• Frantseva MV, Perez Velazquez JL, Carlen PL. Changes in membrane and synaptic properties of thalamocortical circuitry caused by hydrogen peroxide. Neurophysiol 80,1317–1326 (1998).
   PubMed Web of Science ®Google Scholar
• Mailly F, Mann P, Israel M, Glowinski J, Premont J. Increase in external glutamate and NMDA receptor activation contribute to H202-induced neuronal apoptosis. Neurochem. 73,1181-1188 (1999).
   Google Scholar
• Sah R, Schwartz-Bloom RD. Optical imaging reveals elevated intracellular chloride in hippocampal pyramidal neurons after oxidative stress. I Neurosci. 19, 9209–9217 (1999).
   Google Scholar
• Sah R, Galeffi F, Ahrens R, Jordan G, Schwartz-Bloom RD. Modulation of the GABA(A)-gated chloride channel by reactive oxygen species. I Neurochem. 80, 383–391 (2002).
   Google Scholar
• Fattman CL, Schaefer LM, Oury TD. Extracellular superoxide dismutase in biology and medicine. Free Radic. Biol. Med. 35,236–256 (2003).
   PubMed Web of Science ®Google Scholar
• Shaw CA, Bains JS. Synergistic versus antagonistic actions of glutamate and glutathione: the role of excitotoxicity and oxidative stress in neuronal disease. Cell Mal Biol. 48,127–136 (2002).
   PubMed Web of Science ®Google Scholar
• Bains JS, Shaw CA. Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res. Rev. 25,335–358 (1997).
   PubMed Web of Science ®Google Scholar
• Delanty N, Dichter MA. Antioxidant therapy in neurologic disease. Arch. Neural 57,1265–1270 (2000).
   PubMed Web of Science ®Google Scholar
• Muntwyler J, Hennekens CH, Manson JE, Buring JE, Gaziano JM. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch. Intern Med. 162,1472–1476 (2002).
   Google Scholar
• Gaziano JM, Manson JE, Buring JE, Hennekens CH Dietary antioxidants and cardiovascular disease Ann. NY Acacl Sci. 669,249–258 (1992).
   PubMed Web of Science ®Google Scholar
• Gridley G, McLaughlin JK, Block G, Blot WJ, Gluch M, Fraumeni JF Jr. Vitamin supplement use and reduced risk of oral and pharyngeal cancer. Am. I Epidemial 135,1083–1092 (1992).
   Google Scholar
• Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology3, 194–202 (1992).
   Google Scholar
• Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl. Med. 328,1444–1449 (1993).
   PubMed Web of Science ®Google Scholar
• Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. Vitamin E consumption and the risk of coronary heart disease in men. N Engl. Med. 328,1450–1456 (1993).
   PubMed Web of Science ®Google Scholar
• Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek poulation. N Engl. I Med. 348, 2599–2608 (2003).
   PubMed Web of Science ®Google Scholar
• Schmid-Elsaesser R, Zausinger S, Hungerhuber E, Plesnila N, Baethmann A, Reulen HJ. Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood—brain barrier permeability in focal cerebral ischaemia. Stroke 28,2018-2024 (1997).
   Google Scholar
• Andrus PK, Fleck TJ, Oostveen JA, Hall ED. Neuroprotective effects of the novel brain-penetrating pyrrolopyrimidine antioxidants U-101033E and U-104067F against postischaemic degeneration of nigrostriatal neurons. I Neurosci Res. 47,650–654 (1997).
   PubMed Web of Science ®Google Scholar
• Cowers WR. Epilepsy and Other Chronic Convulsive Disorders: Their Cases, Symptoms and Treatment William Wood, NY, USA, 225 (1881).
   Google Scholar
• Murthy VN. Synaptic plasticity: step-wise strengthening. CUI7: Bia 8, R650—R653 (1998).
   Google Scholar
• Triggs WJ, Willmore U. In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection. I Neurochem. 42,976–980 (1984).
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Triggs WJ. Effect of phenytoin and corticosteroids on seizures and lipid peroxidation in experimental posttraumatic epilepsy. I Neurosurg. 60, 467–472 (1984).
   PubMed Web of Science ®Google Scholar
• •Demonstrates that lipid peroxidation is a key factor in the iron chloride animal model of epileptogenesis. Also highlights the lack of effect of phenytoin on lipid peroxidation and lack of effect in preventing the development of post-traumatic epilepsy.
   Google Scholar
• Willmore LJ, Rubin JJ. Formation of malonaldehyde and focal brain oedema induced by subpial injection of FeC12 into rat isocortex. Brain Res. 246,113–119 (1982).
   PubMed Web of Science ®Google Scholar
• •Demonstrates the role of oxidative injury in the iron chloride animal model of epileptogenesis.
   Google Scholar
• Willmore LJ, Hiramatsu M, Kochi H, Mori A. Formation of superoxide radicals after FeC13 injection into rat isocortex. Brain Res. 277,393–396 (1983).
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Triggs WJ, Gray JD. The role of iron-induced hippocampal peroxidation in acute epileptogenesis. Brain Res. 382, 422–426 (1986).
   PubMed Web of Science ®Google Scholar
• Singh R, Pathak DN. Lipid peroxidation and glutathione peroxidase, glutathione reductase, superoxide dismutase, catalase and glucose-6-phosphate dehydrogenase activities in FeC13-induced epileptogenic foci in the rat brain. Epilepsia 31,15–26 (1990).
   PubMed Web of Science ®Google Scholar
• Kabuto H, Yokoi I, Habu H, Willmore LJ, Mori A, Ogawa N. Reduction in nitric oxide synthase activity with development of an epileptogenic focus induced by ferric chloride in the rat brain. Epilepsy Res. 25, 65–68 (1996).
   PubMed Web of Science ®Google Scholar
• Willmore LJ, Triggs WJ. Iron-induced lipid peroxidation and brain injury responses. Int. Dev. Neurosci. 9,175–180 (1991).
   PubMed Web of Science ®Google Scholar
• Ciliffi M, Gentilini G, Franchi-Micheli S, Zilletti L. Lipid peroxidation induced in vivo by iron-carbohydrate complex in the rat brain cortex. Neurochem. Res. 16,43–49 (1991).
   Google Scholar
• Frantseva MV, Velazquez JL, Hwang PA, Carlen PL. Free radical production correlates with cell death in an in vitro model of epilepsy. Etc: j Neurosci. 12, 1431–1439 (2000).
   PubMed Web of Science ®Google Scholar
• Layton ME, Pazdernik TL. Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats. J. Mal Neurosci. 13,63–68 (1999).
   PubMed Web of Science ®Google Scholar
• Frantseva MV, Perez Velazquez JL, Tsoraklidis G et al Oxidative stress is involved in seizure-induced neurodegeneration in the kindling model of epilepsy. Neuroscience 97,431–435 (2000).
   PubMed Web of Science ®Google Scholar
• Kovacs R, Schuchmann S, Gabriel S, Kann O, Kardos J, Heinemann U. Free radical-mediated cell damage after experimental status epilepticus in hippocampal slice cultures. .1. Neurophysiol 88,2909–2918 (2002).
   Google Scholar
• Milatovic D, Zivin M, Gupta RC, Dettbarn WD. Alterations in cytochrome c oxidase activity and energy metabolites in response to kainic acid-induced status epilepticus. Brain Res. 912,67–78 (2001).
   PubMed Web of Science ®Google Scholar
• Kurekci AE, Alpay F, Tanindi S et al Plasma trace element, plasma glutathione peroxidase and superoxide dismutase levels in epileptic children receiving antiepileptic drug therapy. Epilepsia 36,600–604 (1995).
   PubMed Web of Science ®Google Scholar
• Yuksel A, Cengiz M, Seven M, Ulutin T Erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children with valproate and carbamazepine monotherapy. j Basic Gun. Physiol Pharmacol 11, 73–81 (2000).
   Google Scholar
• Cengiz M, Yuksel A, Seven M. The effects of carbamazepine and valproic acid on the erythrocyte glutathione, glutathione peroxidase, superoxide dismutase and serum lipid peroxidation in epileptic children. Pharmacol Res. 41,423–425 (2000).
   Google Scholar
• Sudha K, Rao AV, Rao A. Oxidative stress and antioxidants in epilepsy. Gun. Chim. Acta. 303,19–24 (2001).
   Google Scholar
• Turkdogan D, Toplan S, Karakoc Y. Lipid peroxidation and antioxidative enzyme activities in childhood epilepsy. j Child Neural 17,673–676 (2002).
   Google Scholar
• Verrotti A, Basciani F, Trotta D, Pomilio MP, Morgese G, Chiarelli F. Serum copper, zinc, selenium, glutathione peroxidase and superoxide dismutase levels in epileptic children before and after 1 year of sodium valproate and carbamazepine therapy. Epilepsy Res. 48,71–75 (2002).
   PubMed Web of Science ®Google Scholar
• Yokoi I, Toma J, Liu J, Kabuto H, Mori A. Adenosines scavenged hydroxyl radicals and prevented posttraumatic epilepsy. Free Radic. Biol. Med. 19,473–479 (1995).
   PubMedGoogle Scholar
• Kabuto H, Yokoi I, Ogawa N. Melatonin inhibits iron-induced epileptic discharges in a green tea extract containing ascorbic acid, sunflower seed extract, dunaliella carotene and natural vitamin E. Epilepsia 39, 237–243 (1998).
   Google Scholar
• Yoneda T, Hiramatsu M, Sakamoto M, Togasaki K, Komatsu M, Yamaguchi K. Antioxidant effects of catechin'. Biochem. MoL Biol. Int. 35,995–1008 (1995).
   PubMedGoogle Scholar
• Komatsu M, Hiramatsu M. The efficacy of an antioxidant cocktail on lipid peroxide level and superoxide dismutase activity in aged rat brain and DNA damage in iron-induced epileptogenic foci. Toxicology148, 143–148 (2000).
   PubMed Web of Science ®Google Scholar
• Ramaekers VT, Calomme M, Vanden Berghe D, Makropoulos W Selenium deficiency triggering intractable seizures. Neuropediatric525, 217–223 (1994).
   Google Scholar
• Savaskan NE, Brauer AU, Kuhbacher M et al. Selenium deficiency increases susceptibility to glutamate-induced excitotoxicity. EASE a J. 17,112–114 (2003).
   Google Scholar
• Willmore LJ, Rubin JJ. Antiperoxidant pretreatment and iron-induced epileptiform discharges in the rat: EEG and histopathologic studies. Neurology 31, 63–69 (1981).
   PubMed Web of Science ®Google Scholar
• ••Outlines the effects of vitamin E in animalmodels of epileptogenesis.
   Google Scholar
• Willmore LJ, Rubin JJ. Effects of antiperoxidants on FeC12-induced lipid peroxidation and focal oedema in rat brain. Exp. Neural 83,62–70 (1984).
   Google Scholar
• Levy SL, Burnham WM, Bishai A, Hwang PA. The anticonvulsant effects of vitamin E: a further evaluation. Can. j Neural Li. 19,201–203 (1992).
   PubMed Web of Science ®Google Scholar
• Frantseva MV, Velazquez JL, Hwang PA, Carlen PL. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur. j Neurosci 12, 1431–1439 (2000).
   PubMed Web of Science ®Google Scholar
• Levy SL, Burnham WM, Hwang PA. An evaluation of the anticonvulsant effects of vitamin E. Epilepsy Res. 6,12–17 (1990).
   Google Scholar
• Oztas B, Kilic S, Dural E, Ispir T Influence of antioxidants on the blood—brain barrier permeability during epileptic seizures. Neumsci. Res. 66,674–678 (2001).
   Google Scholar
• Kaya M, Cimen V, Kalayci R et al, and a-tocopherol attenuate blood—brain barrier breakdown in pentylenetetrazole-induced epileptic seizures in acute hyperglycaemic rats. Pharmacol Res. 45,129–133 (2002).
   PubMed Web of Science ®Google Scholar
• Komatsu M, Hiramatsu M, Willmore U. Zonisamide reduces the increase in 8-hydroxy-2'-deoxyguanosine levels formed during iron-induced epileptogenesis in the brains of rats. 43ikpsia 41,1091–1094 (2000).
   Google Scholar
• •Highlights the potential intrinsic antioxidative properties of the novel anticonvulsant zonisamide.
   Google Scholar
• Bialer M, Johannessen SI, Kupfeberg HJ et al Progress report on new antiepileptic drugs: a summary of the sixth Eilat conference (EILAT VI). Epilepsy Res, 51, 31–71 (2002).
   PubMed Web of Science ®Google Scholar
• Isoherranen N, Yagen B, Bialer M. New CNS-active drugs which are second-generation valproic acid: can they lead to the development of a magic bullet? CUI7: Opin. Neural 16,203–211 (2003).
   Google Scholar
• ••Outlines advances and future directions indevelopment of novel anticonvulsants with specific antioxidant properties, particularly the second-generation valproate derivatives.
   Google Scholar
• Bazan NG, Birkle DL, Tang W, Reddy TS. The accumulation of free arachidonic acid, diacylglycerols, prostaglandins and lipoxygenase reaction products in the brain during experimental epilepsy. Adv. Neural 44,879–902 (1986).
   PubMedGoogle Scholar
• Labiner DM. DP-VPA. D-Pharm. Curr. Opin. Invest. Drugs 3,921–923 (2002).
   PubMedGoogle Scholar
• Dawson IQ, Duncan A. Ascorbic acid and long-term anticonvulsant therapy in children. Br. Nutt: 33,315–318 (1975).
   PubMed Web of Science ®Google Scholar
• Ogunmekan AO. Predicting serum vitamin E concentrations from the age of normal and anticonvulsant drug-treated epileptic children using regression equations. Epilepsia 20,295–301 (1979).
   PubMed Web of Science ®Google Scholar
• Kataoka K, Kanamori N, Oishi M, Yarnaji A, Tagawa T, Mimaki T Vitamin E status in pediatric patients receiving antiepileptic drugs. Ebv Phannacol Then 14,96–101 (1989).
   Google Scholar
• Ogunmekan AO. Relationship between age and vitamin E level in epileptic and normal children. Ainj Gun. Nutt: 32,2269–2271 (1979).
   Web of Science ®Google Scholar
• Ogunmekan AO. Plasma vitamin E levels in normal children and in epileptic children with and without anticonvulsant drug therapy. Trap. Geogr Med 37,175–177 (1985).
   PubMedGoogle Scholar
• Krause KH, Bonjour JP, Berlit P, Kynast G, Schmidt-Gayk H, Schellenberg B. Effect of long-term treatment with antiepileptic drugs on the vitamin status. Drug- Nutt: Interact. 5,317–343 (1988).
   PubMedGoogle Scholar
• ••Provides a comprehensive investigationinto the nutritional antioxidant status of patients with epilepsy on anticonvulsant therapy.
   Google Scholar
• Ogunmelcan AO, Hwang PA. A randomised, double-blind, placebo-controlled, clinical trial of D-a-tocopheryl acetate (vitamin E), as add-on therapy, for epilepsy in children. 43ilEpsia 30,84–89 (1989).
   Google Scholar
• ••First study to report evidence for clinicalefficacy of supplemental vitamin E therapy in children with refractory epilepsy. The study followed a substantial body of animal data suggesting that vitamin E and other nutritional antioxidants can reduce both oxidative injury and seizure frequency in various animal models of epileptogenesis.
   Google Scholar
• Raju GB, Behari M, Prasad K, Ahuja GK. Randomised, double-blind, placebo-controlled, clinical trial of D-a-tocopherol (vitamin E) as add-on therapy in uncontrolled epilepsy. Epilepsia 35, 368–372 (1994).
   PubMed Web of Science ®Google Scholar
• ••Quelled the optimism resulting fromOgunmekan's study by reporting a lack of benefit in adults with refractory epilepsy receiving vitamin E supplements.
   Google Scholar
• Gutteridge JM, Westermarck T, Santavuori P. Iron and oxygen radicals in tissue damage: implications for the neuronal ceroid lipofuscinoses. Acta Neural. Land. 68,365-370 (1983).
   Google Scholar
• Marklund SL, Santavuori P, Westermarck T Superoxide dismutase, catalase and glutathione peroxidase in infantile, late infantile and juvenile neuronal ceroid lipofuscinosis. Clin. Chirn. Acta. 116, 191–8 (1981).
   PubMed Web of Science ®Google Scholar
• Marklund SL, Heiskala H, Westermarck T, Santavuori P Superoxide dismutase isoenzymes in cerebrospinal fluid and plasma from patients with neuronal ceroid-lipofuscinoses. Clin Sci 71,57–60 (1986).
   Web of Science ®Google Scholar
• •Outlines studies on neuronal ceroid lipofuscinoses patients searching for primary defect(s) in antioxidant defence mechanisms.
   Google Scholar
• Johansson E, Lindh U, Westermarck T, Heiskala H, Santavuori P Altered elemental profiles in neuronal ceroid lipofuscinosis. Trace Bern. Dectrolytes Health Dis. 4, 139–142 (1990).
   PubMed Web of Science ®Google Scholar
• Kieseier BC, Wisniewski KE, Schuller- Levis G, Park E, Goebel IIf I. Normalsuperoxide radical production in the neuronal ceroid-lipofuscinoses. Neuropediatrics27, 202–203 (1996).
   Google Scholar
• Westermarck T, Aberg L, Santavuori P, Antila E, Edlund P, Atroshi E Evaluation of the possible role of coenzyme Q10 and vitamin E in juvenile neuronal ceroid-lipofuscinosis (NCO. Mal Aspects Med 18, S259—S262 (1997).
   Web of Science ®Google Scholar
• Santavuori P, Westermarck T Antioxidant therapy in neuronal ceroid-lipofuscinosis. Med Biol. 62,152–153 (1984).
   PubMedGoogle Scholar
• •Is of historic importance as the authors describe some benefit conferred by antioxidant therapy in for progressive myoclonic epilepsy of the Unverricht-Lundborg type (PME-UL).
   Google Scholar
• Santavuori P, Heiskala H, Westermarck T, Sainio K, Moren R. Experience over 17 years with antioxidant treatment in Spielmeyer-Sjogren disease. Am J. Med. Genet. (Suppl. 5), 265–274 (1988).
   Google Scholar
• Maertens P, Dyken P, Graf W, Pippenger C, Chronister R, Shah A. Free radicals, anticonvulsants and the neuronal ceroid-lipofuscinoses. Am. J. Med. Genet. 57, 225–228 (1995).
   PubMed Web of Science ®Google Scholar
• Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonic epilepsies. Epilepsy Res. 40,33–39 (2000).
   Google Scholar
• Hurd RVV, Wilder BJ, Helveston WR, Uthman BM. Treatment of four siblings with progressive myoclonus epilepsy of the Unverricht-Lundborg type with N-acetylcysteine. Neurology47, 1264–1268 (1996).
   PubMed Web of Science ®Google Scholar
• ••Reports a beneficial effect onN-acetylcysteine in PME-UL.
   Google Scholar
• Ben-Menachem E, Kyllerman M, Marklund S. Superoxide dismutase and glutathione peroxidase function in progressive myoclonus epilepsies. Epilepsy Res. 40,33–39 (2000).
   Google Scholar
• Selwa LM. N-acetylcysteine therapy for Unverricht-Lundborg disease. Neurology 52,426–427 (1999).
   PubMed Web of Science ®Google Scholar
• Edwards MJ, Hargreaves IP, Heales SJ et al N-acetylcysteine and Unverricht-Lundborg disease: variable response and possible side effects. Neurology59, 1447–1449 (2002).
   PubMed Web of Science ®Google Scholar